SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-047622
Filing Date
2020-08-19
Accepted
2020-08-19 18:45:58
Documents
1
Period of Report
2020-08-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3187
  Complete submission text file 0001209191-20-047622.txt   4673
Mailing Address C/O PANACOS PHARMACEUTICALS, INC. 134 COOLIDGE AVENUE WATERTOWN MA 02472
Business Address
Fischer Laurent (Reporting) CIK: 0001379344 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 201118246

Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)